Form 8-K - Current report:
SEC Accession No. 0001564590-18-008018
Filing Date
2018-04-12
Accepted
2018-04-11 18:00:21
Documents
3
Period of Report
2018-04-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agle-8k_20180411.htm 8-K 33697
2 EX-99.1 agle-ex991_6.htm EX-99.1 1028
3 GRAPHIC g201804112110120259266.jpg GRAPHIC 367312
  Complete submission text file 0001564590-18-008018.txt   541860
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 18750873
SIC: 2834 Pharmaceutical Preparations